消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2018 EASL临床实践指南：酒精性肝病的管理

2018-04-05 欧洲肝脏研究学会 J Hepatol. 2018 Apr 5.

酒精性肝病

2018年4月，欧洲肝脏研究学会(EASL)发布了酒精性肝病的管理指南，指南主要内容包括酒精性肝病的管理的诊断测试，临床管理，酒精相关性肝纤维化和肝硬化的管理，肝移植等。

中文标题：

2018 EASL临床实践指南：酒精性肝病的管理

英文标题：

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.

发布机构：

欧洲肝脏研究学会

发布日期：

2018-04-05

简要介绍：

2018年4月，欧洲肝脏研究学会(EASL)发布了酒精性肝病的管理指南，指南主要内容包括酒精性肝病的管理的诊断测试，临床管理，酒精相关性肝纤维化和肝硬化的管理，肝移植等。

 

拓展指南：与酒精性肝病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 EASL临床实践指南：酒精性肝病的管理)] GetToolGuiderByIdResponse(projectId=1, id=0d38a1c0015e90dc, title=2018 EASL临床实践指南：酒精性肝病的管理, enTitle=EASL Clinical Practice Guidelines: Management of alcohol-related liver disease., guiderFrom=J Hepatol. 2018 Apr 5., authorId=null, author=, summary=2018年4月，欧洲肝脏研究学会(EASL)发布了酒精性肝病的管理指南，指南主要内容包括酒精性肝病的管理的诊断测试，临床管理，酒精相关性肝纤维化和肝硬化的管理，肝移植等。 , cover=, journalId=null, articlesId=null, associationId=84, associationName=欧洲肝脏研究学会, associationIntro=欧洲肝脏研究学会（European Association for the Study of the Liver,EASL），是目前在欧洲居于首要地位的肝病学会，其发布的指南包括各种肝病的处理，同时对诊断、治疗和预防方法进行规范化定义。该协会下属的指南组按疾病划分为肝细胞癌、乙肝、丙肝、酒精性肝病、急性肝衰竭和威尔逊氏病等。其协会官方期刊《Journal of Hepatology》为月刊。, copyright=0, guiderPublishedTime=Thu Apr 05 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年4月，欧洲肝脏研究学会(EASL)发布了酒精性肝病的管理指南，指南主要内容包括酒精性肝病的管理的诊断测试，临床管理，酒精相关性肝纤维化和肝硬化的管理，肝移植等。 </P> <P> </P>拓展指南：<strong>与<font color=red>酒精性肝病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=a149b1c0015e8766" title="酒精性肝病防治指南（2018年更新版）" target=_blank>酒精性肝病防治指南（2018年更新版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=89cdd1c0015e50dd" title="《2018 年美国胃肠病学院酒精性肝病诊治临床指南》推荐意见" target=_blank>《2018 年美国胃肠病学院酒精性肝病诊治临床指南》推荐意见</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f3dfb1c0015a6026" title="2018 ACG临床指南：酒精性肝病" target=_blank>2018 ACG临床指南：酒精性肝病</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7ad0a1c0010163db" title="2013 KASL临床实践指南：酒精性肝病的管理" target=_blank>2013 KASL临床实践指南：酒精性肝病的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4afb61c000915238" title="2012 EASL 酒精性肝病临床实践指南" target=_blank>2012 EASL 酒精性肝病临床实践指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%85%92%E7%B2%BE%E6%80%A7%E8%82%9D%E7%97%85" target=_blank>有关酒精性肝病更多指南</a></ul>, tagList=[TagDto(tagId=307, tagName=酒精性肝病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5509, appHits=188, showAppHits=1, pcHits=4061, showPcHits=1862, likes=156, shares=6, comments=11, approvalStatus=1, publishedTime=Fri Apr 13 22:20:41 CST 2018, publishedTimeString=2018-04-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 13 22:20:41 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 11:28:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 EASL临床实践指南：酒精性肝病的管理)])
2018 EASL临床实践指南：酒精性肝病的管理
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=308573, encodeId=a6e53085e3ce, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJQicDg3XUa0r9HPJF0KVHDpiafHd0K643J27U7iclicSNNTtUsEAof5KuaamibO0n4BWqRteQBC1ZmPdg/132, createdBy=97ed2336261, createdName=许方裕, createdTime=Mon Apr 23 18:26:53 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306946, encodeId=14df3069465e, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:22 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305756, encodeId=e933305e563a, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sat Apr 14 18:48:32 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305664, encodeId=4503305664f6, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Apr 14 08:20:29 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305596, encodeId=b4f03055960c, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 14 06:14:42 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-23 许方裕

    学习了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=308573, encodeId=a6e53085e3ce, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJQicDg3XUa0r9HPJF0KVHDpiafHd0K643J27U7iclicSNNTtUsEAof5KuaamibO0n4BWqRteQBC1ZmPdg/132, createdBy=97ed2336261, createdName=许方裕, createdTime=Mon Apr 23 18:26:53 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306946, encodeId=14df3069465e, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:22 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305756, encodeId=e933305e563a, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sat Apr 14 18:48:32 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305664, encodeId=4503305664f6, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Apr 14 08:20:29 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305596, encodeId=b4f03055960c, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 14 06:14:42 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-18 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=308573, encodeId=a6e53085e3ce, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJQicDg3XUa0r9HPJF0KVHDpiafHd0K643J27U7iclicSNNTtUsEAof5KuaamibO0n4BWqRteQBC1ZmPdg/132, createdBy=97ed2336261, createdName=许方裕, createdTime=Mon Apr 23 18:26:53 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306946, encodeId=14df3069465e, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:22 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305756, encodeId=e933305e563a, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sat Apr 14 18:48:32 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305664, encodeId=4503305664f6, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Apr 14 08:20:29 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305596, encodeId=b4f03055960c, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 14 06:14:42 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-14 cscdliu

    学习了.谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=308573, encodeId=a6e53085e3ce, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJQicDg3XUa0r9HPJF0KVHDpiafHd0K643J27U7iclicSNNTtUsEAof5KuaamibO0n4BWqRteQBC1ZmPdg/132, createdBy=97ed2336261, createdName=许方裕, createdTime=Mon Apr 23 18:26:53 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306946, encodeId=14df3069465e, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:22 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305756, encodeId=e933305e563a, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sat Apr 14 18:48:32 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305664, encodeId=4503305664f6, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Apr 14 08:20:29 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305596, encodeId=b4f03055960c, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 14 06:14:42 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-14 1dd8c52fm63(暂无匿称)

    学习学习.继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=308573, encodeId=a6e53085e3ce, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJQicDg3XUa0r9HPJF0KVHDpiafHd0K643J27U7iclicSNNTtUsEAof5KuaamibO0n4BWqRteQBC1ZmPdg/132, createdBy=97ed2336261, createdName=许方裕, createdTime=Mon Apr 23 18:26:53 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306946, encodeId=14df3069465e, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:22 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305756, encodeId=e933305e563a, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sat Apr 14 18:48:32 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305664, encodeId=4503305664f6, content=学习学习.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Apr 14 08:20:29 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305596, encodeId=b4f03055960c, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat Apr 14 06:14:42 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-14 张新亮1853311252142e2fm

    好文献.学习了

    0

相关指南

酒精性肝病防治指南（2018年更新版）

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) 脂肪肝和酒精性肝病学组 · 2018-03-30

《2018 年美国胃肠病学院酒精性肝病诊治临床指南》推荐意见

暂未更新 · 2018-03-07

2018 ACG临床指南：酒精性肝病

美国胃肠病学院(ACG,American College of Gastroenterology) · 2018-01-16